News

New Jersey State Board of Pharmacy and State’s Attorney General Partner to Provide Pharmacies With Security Best Practice Guidelines

Topics: Diversion and Pharmacies

Best practices for pharmacy security guidelines have been developed by the New Jersey State Board of Pharmacy and the state’s Attorney General to assist pharmacies in preventing drug theft and diversion. 

Read More →

NABP Supports Federal Legislation Creating New Category of Manufacturer Under FDA Oversight, While Maintaining Board of Pharmacy Authority Over Compounding Pharmacies

Topics: Compounding

In testimony presented at a United States Senate Committee Hearing, NABP expressed its support of draft legislation that would create a new category of manufacturer to include entities that engage in large-scale production of sterile non-patient-specific drugs for distribution. 

Read More →

Products Produced by The Compounding Shop Should Be Quarantined Due to Lack of Sterility Assurance, Warns FDA

Topics: Compounding

Medications produced and distributed by The Compounding Shop of St Petersburg, FL, should not be administered to patients and should be quarantined, warns FDA. 

Read More →

Colorado Deploys NABP PMP InterConnect; 15 States Now Sharing PMP Data

Topics: Prescription monitoring program

The Colorado Electronic Prescription Drug Monitoring Program has now deployed the NABP PMP InterConnect®, bringing the total number of live participating state prescription monitoring programs (PMPs) to 15.

Read More →

NABPLAW Online Now Includes Laws and Regulations of Guam, Puerto Rico, and the Virgin Islands

Topics: Pharmacies

The complete pharmacy acts and regulations of Guam, Puerto Rico, and the Virgin Islands are now included in NABPLAW ® Online.

Read More →

NABP Updates VAWD Criteria, Continuing Efforts to Help Secure the Integrity of US Drug Supply Chain for the Protection of Public Health

Topics: Counterfeit drugs and Patient safety

To further protect the integrity of the United States drug supply chain, the National Association of Boards of Pharmacy® (NABP®) has updated the criteria for the Association’s Verified-Accredited Wholesale Distributors® (VAWD®) accreditation program. 

Read More →

USP Prescription Container Labeling Chapter is Now the Official Standard

Topics: Prescription label

The United States Pharmacopeia (USP) General Chapter <17> Prescription Container Labeling, published in the USP 36–NF 31, became an official standard on May 1, 2013.

Read More →

US Senate Committee Proposes Legislation to Create Compounding Manufacturer Category to Be Under FDA Regulation

Topics: Compounding

Federal lawmakers have drafted legislation that would create a new category of drug compounders, “compounding manufacturers,” to be regulated by Food and Drug Administration (FDA). 

Read More →

Sixth DEA Take-Back Day Collects Over 740,000 Pounds of Unneeded Medication, Helping to Prevent Diversion and Abuse

Topics: Medication collection program disposal and Dea

The Drug Enforcement Administration's (DEA) sixth National Prescription Drug Take-Back Day on April 27, 2013, collected twice the amount of unneeded and expired medications for safe disposal than the previous DEA take-back event six months ago.

Read More →

NABP Updates VAWD Criteria, Continuing Efforts to Help Secure the Integrity of US Drug Supply Chain for the Protection of Public Health

Topics: Counterfeit drugs and Patient safety

To further protect the integrity of the United States drug supply chain, the National Association of Boards of Pharmacy® (NABP®) has updated the criteria for the Association’s Verified-Accredited Wholesale Distributors® (VAWD®) accreditation program. 

Read More →

FPGEC and FPGEE Fees to Increase Starting in July

Topics: Fpgee and Fpgec

Effective July 1, 2013, the application fees for the Foreign Pharmacy Graduate Examination Committee (FPGEC) certification, which includes taking the Foreign Pharmacy Graduate Equivalency Examination (FPGEE), will increase.

Read More →